BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1583866)

  • 1. Carrier detection for Sjögren-Larsson syndrome.
    Kelson TL; Craft DA; Rizzo WB
    J Inherit Metab Dis; 1992; 15(1):105-11. PubMed ID: 1583866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.
    Rizzo WB; Craft DA
    J Clin Invest; 1991 Nov; 88(5):1643-8. PubMed ID: 1939650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy of Sjögren-Larsson syndrome heterozygotes.
    Kaminaga T; Mano T; Ono J; Kusuoka H; Nakamura H; Nishimura T
    Magn Reson Med; 2001 Jun; 45(6):1112-5. PubMed ID: 11378890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.
    Rizzo WB; Craft DA; Somer T; Carney G; Trafrova J; Simon M
    J Lipid Res; 2008 Feb; 49(2):410-9. PubMed ID: 17971613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis of Sjögren-Larsson syndrome using enzymatic methods.
    Rizzo WB; Craft DA; Kelson TL; Bonnefont JP; Saudubray JM; Schulman JD; Black SH; Tabsh K; Dirocco M; Gardner RJ
    Prenat Diagn; 1994 Jul; 14(7):577-81. PubMed ID: 7971759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
    Haug S; Braun-Falco M
    Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
    Haug S; Braun-Falco M
    Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete Sjögren-Larsson syndrome in two Japanese siblings.
    Kawakami T; Saito R; Fujikawa Y; Kazama H; Shinomiya N; Yamaguchi K; Yamaguchi Y; Aoki T; Kobayashi T
    Dermatology; 1999; 198(1):93-6. PubMed ID: 10026413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sjögren-Larsson syndrome: inherited defect in the fatty alcohol cycle.
    Rizzo WB; Dammann AL; Craft DA; Black SH; Tilton AH; Africk D; Chaves-Carballo E; Holmgren G; Jagell S
    J Pediatr; 1989 Aug; 115(2):228-34. PubMed ID: 2666627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.
    Rizzo WB; Carney G; Lin Z
    Am J Hum Genet; 1999 Dec; 65(6):1547-60. PubMed ID: 10577908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing Sjögren-Larsson syndrome in a 7-year-old Moroccan boy.
    Bernardini ML; Cangiotti AM; Zamponi N; Porfiri L; Cinti S; Offidani A
    J Cutan Pathol; 2007 Mar; 34(3):270-5. PubMed ID: 17302612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bezafibrate induces FALDH in human fibroblasts; implications for Sjögren-Larsson syndrome.
    Gloerich J; Ijlst L; Wanders RJ; Ferdinandusse S
    Mol Genet Metab; 2006; 89(1-2):111-5. PubMed ID: 16837225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.
    De Laurenzi V; Rogers GR; Hamrock DJ; Marekov LN; Steinert PM; Compton JG; Markova N; Rizzo WB
    Nat Genet; 1996 Jan; 12(1):52-7. PubMed ID: 8528251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common deletion mutation in European patients with Sjögren-Larsson syndrome.
    Rizzo WB; Carney G; De Laurenzi V
    Biochem Mol Med; 1997 Dec; 62(2):178-81. PubMed ID: 9441870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of microsomal fatty aldehyde dehydrogenase in the alpha-oxidation of phytanic acid.
    Verhoeven NM; Jakobs C; Carney G; Somers MP; Wanders RJ; Rizzo WB
    FEBS Lett; 1998 Jun; 429(3):225-8. PubMed ID: 9662422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic diagnosis of Sjögren-Larsson syndrome using electrospray ionization mass spectrometry.
    Sanders RJ; Ofman R; Dekker C; Kemp S; Wanders RJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):451-5. PubMed ID: 19124283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sjogren-Larsson syndrome associated hypermelanosis.
    Xu YC; Hou JQ; Zhu WJ; Li P
    J Cosmet Dermatol; 2020 Apr; 19(4):789-798. PubMed ID: 31697031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sjögren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2).
    Rizzo WB; Carney G
    Hum Mutat; 2005 Jul; 26(1):1-10. PubMed ID: 15931689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.
    Rizzo WB; Heinz E; Simon M; Craft DA
    Biochim Biophys Acta; 2000 Dec; 1535(1):1-9. PubMed ID: 11113626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel assay for the prenatal diagnosis of Sjögren-Larsson syndrome.
    van den Brink DM; van Miert JM; Wanders RJ
    J Inherit Metab Dis; 2005; 28(6):965-9. PubMed ID: 16435189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.